Physician profile
Sibi Krishnamurthy
NPI 1043672181
$23,282.30
in general payments reported to CMS, 2019-2025
32 companies · $5,495 in 2025
The $5,495 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $335 · 2021: $550 · 2022: $4,056 · 2023: $8,008 · 2024: $4,072 · 2025: $5,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $3,254 · Consulting Fee: $530 · Grant: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,518.89 |
| Travel and Lodging | $3,254.47 |
| Consulting Fee | $530.00 |
| Grant | $271.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,263.04 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $3,903.60 | 2019-2025 | Watchman Access System, Rotapro, Avvigo Guidance System |
| Shockwave Medical, INC | $3,295.34 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $3,177.40 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Ffrangio |
| Abbott Laboratories | $2,045.20 | 2023-2025 | Mitraclip, Navitor, Coroflow |
| Biotronik INC. | $1,053.82 | 2022-2024 | Recross, Orsiro Mission, Pk Papyrus |
| Abiomed | $828.61 | 2023-2025 | Impella |
| Chiesi USA, INC. | $588.70 | 2022-2024 | Kengreal, Cleviprex |
| Cardiovascular Systems INC. | $467.49 | 2022-2023 | Diamondback Peripheral, Diamondback Coronary |
| Akcea Therapeutics, INC. | $445.12 | 2019-2020 | |
| Inari Medical, INC. | $420.64 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $335.90 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $330.32 | 2019-2023 | Farxiga, Andexxa |
| Lantheus Medical Imaging, INC. | $305.11 | 2019 | |
| Pfizer INC. | $285.33 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $255.28 | 2022-2023 | |
| Penumbra, INC. | $251.83 | 2024 | Indigo System |
| Cardiva Medical, INC. | $218.63 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiac Dimensions, INC. | $148.19 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $124.89 | 2022 | |
| Amgen INC. | $99.30 | 2021 | |
| Jenavalve Technology, INC. | $97.63 | 2023 | Jenavalve Pericardial Tavr System |
| Alnylam Pharmaceuticals INC. | $89.19 | 2024 | Amvuttra |
| Teleflex LLC | $51.99 | 2023-2024 | Turnpike, Supercross |
| W. L. Gore & Associates, INC. | $45.48 | 2023 | Gore Cardioform Septal Occluder |
| Kestra Medical Technology Services, INC. | $38.53 | 2024 | Assure Wcd |
| Terumo Medical Corporation | $30.98 | 2025 | Tr Band |
| Getinge USA Sales, LLC | $25.82 | 2023 | Cardiosave Hybrid, Type B Plug |
| Sobi, INC | $22.21 | 2021 | |
| Avanos Medical | $15.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2023 | Xarelto |
| Reflow Medical INC | $7.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sibi Krishnamurthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.